DAWN AC Newsletters – 2017

December 2017 

DAWN support desk holiday closures
Independent Checking of Dose and Next Test Intervals – including DAWN clinic checklists
New DAWN interface with Allscripts
Customer support resources
Online training resources
Expand your capabilities with DAWN
Oral Agents for Cancer-Related VTE: ‘New Standard of Care’
DOACs vs warfarin for stroke prevention in atrial fibrillation

November 2017

Power Outage at 4S DAWN offices – Monday 4th December
Important reminder – patient identifiable data
New Customer Support Notices
DAWN AC North American User Group – Proceedings document now available
Expand your capabilities with DAWN
Impact of Oral Anticoagulants on Renal Outcomes Compared
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation
Anticoagulation after ischemic stroke: microbleeds predict ICH

October 2017

The importance of a robust non-attendance (DNA) process
Safety Notice – New recommendation for test interval settings
Another successful year for the DAWN AC User Groups – UK and North America
Don’t miss key information – DAWN Front screen tallies
Expand your capabilities with DAWN
Concurrent use of anticoagulants and other drugs raise bleeding risk in atrial fibrillation
Genetic testing can improve safety of common blood thinner, study shows

September 2017

25th Annual DAWN AC UK User Group – last chance to register!
11th DAWN AC North American User Group
Reminder: Checking system settings for dosing and other safety aspects
New list view for accessing recently viewed patients
DAWN Hold Monitor guide
Expand your capabilities with DAWN
Newer drugs drive rise in oral anticoagulant use among patients with atrial fibrillation
Remote AF Screening by Patients Boosts Detection: REHEARSE-AF
Education and Monitoring Improves the Use of Stroke-Prevention Therapies

August 2017

DAWN support desk closures
25th Annual DAWN AC UK User Group
11th Annual DAWN AC North American User Group
DAWN Point of Care (PoC) interfaces (Roche and Alere)
Post clinic checklist to enhance patient safety
Front Screen Tallies: Key patient information and checking your DAWN system is working smoothly
Expand your capabilities with DAWN
Patients with paroxysmal AF may be undertreated with anticoagulants
Optical sensing of anticoagulation status: Towards point-of-care coagulation testing
Anticoagulants reduce portal vein thrombosis progression in cirrhosis

July 2017

Safety Improvement and new features on DAWN DOAC questionnaires
DAWN support desk closures
NEW – Receive email alerts for results in the DAWN Hold Monitor
25th Annual DAWN AC UK User Group
11th DAWN AC North American User Group
Expand your capabilities with DAWN
FDA approves betrixaban for hospital and extended duration prevention of VTE in acutely ill
Early cardiology care linked to lower risk of stroke in patients with atrial fibrillation
CHMP Issues a Positive Opinion for Daiichi Sankyo’s Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion
Idarucizumab reverses anticoagulant effect of dabigatran in emergency situations

June 2017

Latest Release – Version 7.9.67
25th Annual DAWN AC UK User Group
11th DAWN AC North American User Group
DAWN DOAC Modules
DAWN VTE Diagnosis & Assessment Module
Expand your capabilities with DAWN
Researchers warn of ‘treatment gap’ for patients with intermittent atrial fibrillation
Restarting anticoagulation may be cost-effective in some VTE cases

May 2017

FREE Online Training Resources
Access the DAWN AC User and Safety Manual
New Point of Care interfaces
DAWN INR Capture for self-testing
25th Annual DAWN AC UK User Group
11th DAWN AC North American User Group
Expand your capabilities with DAWN
REVEAL-AF: Silent AF Common in Patients at Risk for AF, Stroke
ORBIT Score Pinpoints Repeat GI Bleeds with Anticoagulation
Aspirin not an effective treatment for atrial fibrillation, study suggests

April 2017

DAWN support desk closures
Work Smarter: DAWN Version 7.9.66
25th Annual DAWN AC UK User Group
Post clinic checklist to enhance patient safety
Front Screen Tallies: Key patient information and checking your DAWN system is working smoothly
Expand your capabilities with DAWN
Patient’s Blood Thinner History Critical to Emergency Medical Services Triage
Artificial intelligence increases adherence to anticoagulation therapy
Praxbind earns new UK status as antidote to Pradaxa

March 2017

NOW AVAILABLE – Edoxaban Module for DAWN AC
24th Annual DAWN AC UK User Group – Proceedings Document
Come and visit us at the North American AC Forum
25th Annual DAWN AC UK User Group
Introducing My Inhealthcare, a new smartphone app for patient self-testing
Expand your capabilities with DAWN
Resuming Oral Anticoagulation Benefits Even After Lobar ICH
Most atrial fibrillation patients don’t get preventive drug before stroke
Some blood thinners may increase heart attack risk

February 2017 

Come and visit us at the North American AC Forum
25th Annual DAWN AC UK User Group
Apixaban & Edoxaban Modules for DAWN AC
Resetting your DAWN password – help and guidance
New way to keep up to date and connect with 4S DAWN
Few Outcomes Differences Seen for Reduced-Dose NOACs in AFib
Stroke Risk Lower for Paroxysmal vs Persistent or Permanent AF: ENGAGE AF-TIMI 48
ACC guidance on periprocedural anticoagulation in A-fib falls short

January 2017

Work Smarter – DAWN Version 7.9.61
DAWN AC North American User Group Proceedings Document
Customer Support Resources
Expand your capabilities with DAWN
Oral Anticoagulant Betrixaban Wins Priority Review
Atrial fibrillation patients more likely to discontinue anticoagulant therapy after procedure, research finds
American College of Cardiology Issues Decision-Making Guide for Periprocedural Management of Anticoagulation in Nonvalvular Atrial Fibrillation